This page includes the latest FDA filings for Nymox Pharmaceutical Corp. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
CANADA | NASDAQ | NYMX | DUNS 253307326 |
Registration Number | 3003611012 |
FEI Number | 3003611012 |
Name | NYMOX PHARMACEUTICAL CORPORATION |
Owner & Operator | NYMOX CORPORATION |
Contact Address | 777 TERRACE AVE., 3RD FL. -- Hasbrouck Heights NJ 07604 US |
Official Correspondent |
|
US Agent |
|
Registration Status | 1 |
Initial Importer | N |
Registration Expiration | 2020-04-25 |
Registration Address | 9900 CAVENDISH BLVD. SUITE 206 ST.-LAURENT Quebec, H4M 2V2 CA |
Establishment Type | Develop Specifications But Do Not Manufacture At This Facility |
Device Company | Device | Date |
---|---|---|
NYMOX PHARMACEUTICAL CORPORATION [NYMOX CORPORATION] | NicAlert | 2007-12-11 |
NYMOX PHARMACEUTICAL CORPORATION [NYMOX CORPORATION] | NicAlert | 2007-12-11 |
NYMOX PHARMACEUTICAL CORPORATION | NICALERT | 2002-10-18 |
SEC | 0001018735 | NYMOX PHARMACEUTICAL CORP |